Many B2B organisations focus heavily on generating leads and closing deals, but the middle of the funnel is often where growth actually stalls.
This stage is where prospects move from initial interest into active evaluation. In sectors such as Life Sciences, buying decisions are rarely immediate. Buyers need reassurance, technical confidence, and evidence before progressing further.
Three common middle-of-funnel issues
1. Lead generation outpaces lead nurturing
Many companies invest heavily in awareness campaigns but fail to maintain meaningful engagement once prospects enter the funnel. At this stage, buyers are not looking for aggressive sales messaging; instead, they are trying to better understand their problem, available approaches, risks involved and which provider appears credible.
Effective middle-of-funnel content helps buyers evaluate with confidence rather than pushing prematurely for conversion.
2. Buyers need proof, not promotion
In complex B2B sectors, promotional messaging alone is rarely enough to drive conversions at scale, because scientific audience are often assessing implementation risk as much as capability, which is why content such as:
- case studies
- technical explainers
- webinars
- buyer guides
can become highly influential during evaluation. The goal isn't just about generating visibility, but to help reduce uncertainty.
3. Lead volume can hide conversion problems
A strong flow of leads does not necessarily indicate a healthy funnel. Signals such as repeat engagement, stakeholder involvement, and content depth are often better indicators of genuine buying intent than raw lead numbers alone.
The middle of the funnel is where buyers decide which organisations are worth serious consideration. Businesses that educate effectively during this stage and provide value, tend to build stronger trust and better conversion outcomes later in the process.
This article is adapted from Qincade’s broader analysis of middle-of-funnel optimisation, including nurturing strategy, conversion diagnostics, and content evaluation for complex B2B buying journeys.
Read the full article here: MOFU marketing in Life Sciences
